From: Dynamic changes of CSF clusterin levels across the Alzheimer’s disease continuum
Characteristics | A-(TN)- | A+(TN)- | A+(TN)+ | A-(TN)+ | P |
---|---|---|---|---|---|
N | 50 | 39 | 147 | 40 | |
Clinical diagnosis details (n, %) | |||||
CU | 37(44.05) | 13(15.48) | 16(19.04) | 18(21.43) | |
MCI | 11(9.40) | 6(5.13) | 82(70.09) | 18(15.38) | |
AD | 2(2.67) | 20(26.67) | 49(65.33) | 4(5.33) | |
Age (Mean ± SD, years) | 74.53 ± 6.09 | 75.58 ± 5.23 | 74.66 ± 7.26 | 77.00 ± 7.46 | 0.232a |
Gender (F/M) | 19/31 | 12/27 | 61/86 | 17/23 | 1.000b |
Education (Mean ± SD, years) | 15.28 ± 3.01 | 15.51 ± 3.50 | 15.83 ± 2.93 | 16.10 ± 2.62 | 0.514a |
APOE ε4 (n, %) | 3 (6.00) | 20 (51.28) | 102 (69.39) | 7 (17.50) | < 0.001b |
MMSE score | 28.44 ± 1.47 | 26.51 ± 2.45 | 25.69 ± 3.31 | 28.20 ± 1.74 | < 0.001a |
CSF biomarker | |||||
Aβ42 (pg/ml) | 1441.64 ± 252.09 | 639.87 ± 194.49 | 587.76 ± 176.21 | 1794.03 ± 664.20 | < 0.001a |
t-tau (pg/ml) | 191.10 ± 31.10 | 181.61 ± 33.97 | 353.71 ± 97.99 | 320.71 ± 81.04 | < 0.001a |
p-tau (pg/ml) | 16.78 ± 2.87 | 16.66 ± 3.53 | 35.99 ± 10.63 | 29.09 ± 9.66 | < 0.001a |
Clusterin | 20.56 ± 0.45 | 20.24 ± 0.45 | 20.38 ± 2.02 | 20.98 ± 0.36 | < 0.001a |